“…C-terminal, non-sulphated fragments of gastrin with thirteen or more amino-acid residues are equipotent with synthetic human gastrin heptadecapeptide, non-sulphate (shG17ns) in both the cat and dog, whilst shorter fragments show a progressive diminution in potency (Hirst, Reed & Shaw, 1977;Strunz, Thompson, Elashoff & Grossman, 1978;Blair, Hirst, Lund, Reed, Sanders & Shaw, 1980;Hirst & Shaw, 1981). Sulphation of the tyrosyl residue in such short fragments is associated with increased potency (Anastasi, Bernardi, Bertaccini, Bosisio, de Castiglione, Erspamer, Goffredo & Impicciatore, 1968;Negri & Erspamer, 1973;de Castiglione, 1977;Hirst, Reed, Shaw, Smeaton, Blair & de Castiglione, 1979). However, the comparison of biological potency based solely upon exogenous doses in vivo does not necessarily reflect the affinity of the peptides for their receptors; differential clearance or delivery rates are likely to contribute significantly to potencies so measured.…”